Search research articles
Contact Us
Filters
Showing results (1-10 of 520) with videos related to
Page
of 52
Sort By:
Expert Review of Anticancer Therapy
|
December 23, 2003
Chemoprevention of superficial bladder cancer
Ashish M Kamat
Urologic Oncology
|
June 26, 2013
Commentary on "Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder." Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM. Department of Urology, Central Hospital of Bolzano, Bolzano, Italy: BJU Int 2012;110(6 Pt B):E222-7 [Epub 2012 Feb 7]
Ashish M Kamat
European Urology
|
June 16, 2016
Corrigendum re: "Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin" [Eur Urol 2016;69:197-200]
Ashish M Kamat
Urologic Oncology
|
September 9, 2010
To the editor: response to Barlow et al, Urol Oncol 2010
Ashish M Kamat
The Journal of Urology
|
July 29, 2011
Is repeat transurethral resection needed for minimally invasive T1 urothelial cancer? Con
Ashish M Kamat
Urologic Oncology
|
June 26, 2013
Commentary on "Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience." Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W. Department of Surgery (Urology), McGill University, Quebec, Canada: BJU Int 2012;110(9):1317-23 [Epub 2012 Apr 13]
Ashish M Kamat
European Urology
|
May 4, 2020
Bladder Cancer Guidelines: Let Not the Cure Be Worse than the Disease
Ashish M Kamat
Cancer
|
June 11, 2008
Intravesical BCG for bladder cancer: how much is enough?
Ashish M Kamat
Urologic Oncology
|
June 26, 2013
Commentary on "Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinoma." Wong YN, Litwin S, Vaughn D, Cohen S, Plimack ER, Lee J, Song W, Dabrow M, Brody M, Tuttle H, Hudes G, University of Pennsylvania, Philadelphia, PA: J Clin Oncol 2012;30(28):3545-51 [Epub 2012 Aug 27]
Ashish M Kamat
Urologic Oncology
|
June 26, 2013
Commentary on "The clinical epidemiology of urachal carcinoma: results of a large, population based study." Bruins HM, Visser O, Ploeg M, Hulsbergen-van de Kaa CA, Kiemeney LA, Witjes JA, Department of Urology, Radboud University Medical Centre, Utrecht, The Netherlands: J Urol 2012;188(4):1102-7 [Epub 2012 Aug 15]
Ashish M Kamat
Page
of 52
Search research articles
Search
Showing results (1-10 of 520) with videos related to
Sort By:
Page
of 52
Expert Review of Anticancer Therapy
|
December 23, 2003
Chemoprevention of superficial bladder cancer
Ashish M Kamat
Urologic Oncology
|
June 26, 2013
Commentary on "Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder." Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM. Department of Urology, Central Hospital of Bolzano, Bolzano, Italy: BJU Int 2012;110(6 Pt B):E222-7 [Epub 2012 Feb 7]
Ashish M Kamat
European Urology
|
June 16, 2016
Corrigendum re: "Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin" [Eur Urol 2016;69:197-200]
Ashish M Kamat
Urologic Oncology
|
September 9, 2010
To the editor: response to Barlow et al, Urol Oncol 2010
Ashish M Kamat
The Journal of Urology
|
July 29, 2011
Is repeat transurethral resection needed for minimally invasive T1 urothelial cancer? Con
Ashish M Kamat
Urologic Oncology
|
June 26, 2013
Commentary on "Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience." Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Saad F, Drachenberg D, Kassouf W. Department of Surgery (Urology), McGill University, Quebec, Canada: BJU Int 2012;110(9):1317-23 [Epub 2012 Apr 13]
Ashish M Kamat
European Urology
|
May 4, 2020
Bladder Cancer Guidelines: Let Not the Cure Be Worse than the Disease
Ashish M Kamat
Cancer
|
June 11, 2008
Intravesical BCG for bladder cancer: how much is enough?
Ashish M Kamat
Urologic Oncology
|
June 26, 2013
Commentary on "Phase II trial of cetuximab with or without paclitaxel in patients with advanced urothelial tract carcinoma." Wong YN, Litwin S, Vaughn D, Cohen S, Plimack ER, Lee J, Song W, Dabrow M, Brody M, Tuttle H, Hudes G, University of Pennsylvania, Philadelphia, PA: J Clin Oncol 2012;30(28):3545-51 [Epub 2012 Aug 27]
Ashish M Kamat
Urologic Oncology
|
June 26, 2013
Commentary on "The clinical epidemiology of urachal carcinoma: results of a large, population based study." Bruins HM, Visser O, Ploeg M, Hulsbergen-van de Kaa CA, Kiemeney LA, Witjes JA, Department of Urology, Radboud University Medical Centre, Utrecht, The Netherlands: J Urol 2012;188(4):1102-7 [Epub 2012 Aug 15]
Ashish M Kamat
Page
of 52